Cigna Group $CI Shares Sold by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC cut its position in shares of Cigna Group (NYSE:CI) by 76.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 690 shares of the health services provider’s stock after selling 2,237 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Cigna Group were worth $228,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the company. Brighton Jones LLC grew its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Private Advisor Group LLC grew its holdings in Cigna Group by 11.8% during the 1st quarter. Private Advisor Group LLC now owns 15,645 shares of the health services provider’s stock valued at $5,147,000 after buying an additional 1,650 shares during the last quarter. Csenge Advisory Group increased its position in Cigna Group by 33.1% during the first quarter. Csenge Advisory Group now owns 1,326 shares of the health services provider’s stock worth $438,000 after buying an additional 330 shares in the last quarter. Elyxium Wealth LLC acquired a new position in shares of Cigna Group in the first quarter worth $258,000. Finally, OneAscent Financial Services LLC lifted its position in shares of Cigna Group by 102.6% in the first quarter. OneAscent Financial Services LLC now owns 3,712 shares of the health services provider’s stock valued at $1,224,000 after acquiring an additional 1,880 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CI shares. Cowen reiterated a “buy” rating on shares of Cigna Group in a report on Tuesday, November 4th. Wolfe Research lowered their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. Robert W. Baird set a $372.00 price target on Cigna Group in a research note on Thursday, August 14th. JPMorgan Chase & Co. decreased their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. Finally, TD Cowen dropped their target price on Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $334.05.

Insider Activity at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

Shares of NYSE:CI opened at $270.84 on Tuesday. The firm has a market capitalization of $72.35 billion, a PE ratio of 14.78, a P/E/G ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The business has a 50-day moving average of $289.16 and a two-hundred day moving average of $300.40. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.